Should management be the same in thyroid peroxidase antibody (TPOAb)-negative and TPOAb-positive women with subclinical hypothyroidism who are planning a pregnancy and who are newly pregnant?
How to manage a woman with subclinical hypothyroidism who is planning a pregnancy? Is this management different in a woman in the first trimester of pregnancy?
What antihypertensive drugs can be used in a patient undergoing a diagnostic workup of primary hyperaldosteronism?
Is there ever a need for hormone replacement therapy with levothyroxine in thyroid peroxidase antibody (TPOAb)-negative pregnant women with subclinical hypothyroidism?
What are the indications for screening for primary hyperaldosteronism?
What are the diagnostic criteria for subclinical hypothyroidism in pregnant women? Do they differ from the criteria used in the general population?
It is now recommended to use population-based trimester-specific thyroid-stimulating hormone (TSH) reference ranges, but what should be the optimal TSH level for a woman before pregnancy?
Should separate thyroid-stimulating hormone (TSH) reference ranges be determined for different age groups in the general population?
How to treat patients with hypertension and metabolic syndrome? Do you agree with the opinion that beta-blockers and diuretics are contraindicated in such patients?
Are any classes of antihypertensive drugs preferred in patients with diabetes?
English
Polski
Español
українська